Not an eMediNexus Member?
Over half of patients hospitalized with COVID-19 have prothrombotic antiphospholipid (aPL) autoantibodies in their blood that ma ...MORE
An evaluation of the heart after death from COVID-19 has revealed that cardiac damage was common, but more from clotting in comp ...MORE
Prothrombotic autoantibodies were shown to be raised in COVID-19 and associated with the development of thrombosis, suggested a ...MORE
Some rashes seen in severe COVID-19 patients may be a clinical clue to an underlying thrombotic state, suggest researchers.
Preemptive therapeutic-dose anticoagulation for patients hospitalized with COVID-19 was not associated with better outcomes in a ...MORE
Following hospitalization for medical illness, an extended course of low-dose anticoagulation reduced arterial and venous thromb ...MORE